Tan – Center for Virology and Vaccine Research (CVVR)

Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial

2020-02-17/in Stephenson, Tan, Walsh

Stephenson KE, Wegmann F, Tomaka F, et al. Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22) [published online ahead of print, 2020 Feb 17] [published correction appears in Lancet HIV. 2020 Feb 28;:]. Lancet HIV. 2020;S2352-3018(20)30001-1. doi:10.1016/S2352-3018(20)30001-1

Survey of BK virus screening practices by American Society of Transplantation members.

2019-05-01/in Tan

Tan CS, Gabardi S, Pavlakis M, Survey of BK virus screening practices by American Society of Transplantation members. Clin Transplant; 2019 (In Press) PMID 31152561

Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4(+) and CD8(+) T effector memory cells and increase of T regulatory cells.

2019-05-01/in Tan

Karantanos T, Kim HT, Tijaro-Ovalle NM, Li L, Cutler C, Antin JH, Ballen K, Marty FM, Tan CS, Ritz J, Politikos I, Boussiotis V. Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4(+) and CD8(+) T effector memory cells and increase of T regulatory cells. Clin Immunol. 2019 PMID 31255803.

NK Cells Contribute to the Immune Risk Profile in Kidney Transplant Candidates.

2019-05-01/in Jost, Tan

DeWolfe D, Aid M, McGann K, Ghofrani J, Geiger E, Helzer C, Malik S, Kleiboeker S, Jost S, Tan CS. NK Cells Contribute to the Immune Risk Profile in Kidney Transplant Candidates. (2019) Frontiers in Immunology. 10:1890.

Decreased JC virus-specific antibody-dependent cellular cytotoxicity in HIV-seropositive PML survivors

2019-05-01/in Jost, Researchers, Tan

Tan CS., Ghofrani J., Geiger E., Koralnik IJ, Jost S., Decreased JC virus-specific antibody-dependent cellular cytotoxicity in HIV-seropositive PML survivors. JAIDS; 2019 (In Press)

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.

2018-05-01/in Seaman, Tan

Modjarrad K, Lin L, George SL, Stephenson KE, Eckels KH, De La Barrera RA, Jarman RG, Sondergaard E, Tennant J, Ansel JL, Mills K, Koren M, Robb ML, Barrett J, Thompson J, Kosel AE, Dawson P, Hale A, Tan CS, Walsh SR, Meyer KE, Brien J, Crowell TA, Blazevic A, Mosby K, Larocca RA, Abbink P, Boyd M, Bricault CA, Seaman MS, Basil A, Walsh M, Tonwe V, Hoft DF, Thomas SJ, Barouch DH*, Michael NL*. Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials. Lancet 2018; 391:563-571.

Reactivation of Multiple Infectious Pathogens after Hematopoietic Stem Cell Transplantation.

2017-05-01/in Tan

Tan CS. Reactivation of Multiple Infectious Pathogens after Hematopoietic Stem Cell Transplantation. Acta Haematol 2017; 138(1): 1-2.

Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients.

2017-05-01/in Tan

DeWolfe D, Gandhi J, Mackenzie MR, Broge TA Jr, Bord E, Babwah A, Mandelbrot DA, Pavlakis M, Cardarelli F, Viscidi R, Chandraker A, Tan CS. Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients. PLoS One. 2017;12(5):e0177339. doi: 10.1371/journal.pone.0177339. eCollection 2017. PubMed PMID: 28562595; PubMed Central PMCID: PMC5451008.

BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation.

2015-05-01/in Tan

Satyanarayana G, Hammond SP, Broge TA Jr, Mackenzie MR, Viscidi R, Politikos I, Koralnik IJ, Cutler CS, Ballen K, Boussiotis V, Marty FM, Tan CS. BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation. Transpl Immunol. 2015 Mar;32(2):116-20. doi: 10.1016/j.trim.2014.12.002. Epub 2014 Dec 20. PubMed PMID: 25536223; PubMed Central PMCID: PMC4368450.

Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.